DataMeds AI and Tollo Health have joined forces with the National Football League Alumni Association’s subsidiary, Alumni Health, to kickstart the “Health Lives Here” campaign. This nationwide health initiative aims to enhance healthcare accessibility by providing crucial information, pharmacy services, and health-management tools to underserved and rural communities. Central to this effort is leveraging DataMeds AI’s expansive network of over 6,500 independent pharmacies to boost awareness about healthy living while offering consumers discounted pharmacy services and other healthcare resources.
A pivotal element of this initiative is the development of the “Health Lives Here” mobile application. This consumer-centric platform is designed to facilitate telehealth services and health management. Users will be able to centralize and manage their electronic health records and sync data from wearable devices into a comprehensive health dashboard. Additionally, the app will offer access to pharmacy-related services and selected healthcare products, ensuring users have a holistic approach to managing their health.
The “Health Lives Here” initiative was introduced to former professional football players during the 2026 Football Hall of Fame Game weekend held in Canton, Ohio. Following this initial introduction, the campaign is set to expand its reach to the general public in North Carolina starting September 2026. Further details about the mobile application, the pharmacies involved, and the overall campaign rollout are anticipated to be shared in due course.
This strategic partnership brings together Tollo Health’s expertise in medical food and nutraceutical products with DataMeds AI’s advanced healthcare technology and extensive pharmacy infrastructure. The NFL Alumni Association’s health network will play a crucial role by supporting outreach efforts to communities and former professional football players, ensuring that the campaign effectively reaches its target audience.
For more information, James Lambert, the Vice President of Rubenstein Public Relations, can be contacted at 212-805-3024 or via email at [email protected]. Investor-related inquiries can be directed to the DataMeds AI Investor Relations team at [email protected]. Additional information is available on their website at https://datamedsai.com/.
Legal Disclaimer: The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.